Technical Analysis for ACST - Acasti Pharma, Inc.

Grade Last Price % Change Price Change
grade F 1.04 0.00% 0.00
ACST closed unchanged on Friday, February 16, 2018, on 18 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
2 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ACST trend table...

Date Alert Name Type % Chg
Feb 16 Narrow Range Bar Range Contraction 0.00%
Feb 16 NR7 Range Contraction 0.00%
Feb 16 NR7-2 Range Contraction 0.00%
Feb 16 Wide Bands Range Expansion 0.00%
Feb 15 Narrow Range Bar Range Contraction 0.00%
Feb 15 NR7 Range Contraction 0.00%
Feb 15 Wide Bands Range Expansion 0.00%
Feb 14 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.95%
Feb 14 Wide Bands Range Expansion -0.95%
Feb 13 MACD Bullish Signal Line Cross Bullish -2.80%

Older signals for ACST ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
Is ACST a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.36
52 Week Low 0.84
Average Volume 536,235
200-Day Moving Average 1.2897
50-Day Moving Average 1.1234
20-Day Moving Average 1.0925
10-Day Moving Average 1.046
Average True Range 0.0795
ADX 13.83
+DI 22.32
-DI 17.86
Chandelier Exit (Long, 3 ATRs ) 1.0615
Chandelier Exit (Short, 3 ATRs ) 1.2085
Upper Bollinger Band 1.2229
Lower Bollinger Band 0.9621
Percent B (%b) 0.3
BandWidth 23.871854
MACD Line -0.0241
MACD Signal Line -0.0255
MACD Histogram 0.0014
Fundamentals Value
Market Cap 15.3 Million
Num Shares 14.7 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -1.35
Price-to-Sales 0.00
Price-to-Book 1.22
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.08
Resistance 3 (R3) 1.08 1.07 1.08
Resistance 2 (R2) 1.07 1.06 1.07 1.07
Resistance 1 (R1) 1.05 1.05 1.05 1.05 1.07
Pivot Point 1.04 1.04 1.04 1.04 1.04
Support 1 (S1) 1.02 1.03 1.03 1.03 1.01
Support 2 (S2) 1.01 1.02 1.01 1.01
Support 3 (S3) 0.99 1.01 1.00
Support 4 (S4) 1.00